Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 May;105(5):e70116.
doi: 10.1111/cbdd.70116.

Artesunate Enhances Sensitivity of Renal Cancer Cells to Sunitnib by Mediating Tripartite Motif Containing 24-Induced Ubiquitination of Paired Box 6

Affiliations

Artesunate Enhances Sensitivity of Renal Cancer Cells to Sunitnib by Mediating Tripartite Motif Containing 24-Induced Ubiquitination of Paired Box 6

Zelin Cui et al. Chem Biol Drug Des. 2025 May.

Abstract

This research aims to elucidate the mechanistic role of artesunate (ART) in enhancing the sensitivity of renal cell carcinoma (RCC) to sunitinib. To establish sunitinib-resistant RCC cell lines (786-O R and Caki-1 R), cells were treated with different concentrations of sunitinib and ART. The viability of the cells was measured through the cell counting kit-8 (CCK-8) assay. Tripartite motif-containing 24 (TRIM24) and paired box 6 (PAX6) expression were suppressed with lentiviral vectors, quantified by reverse transcription-quantitative polymerase chain reaction (RT-qPCR) and western blot (WB) analysis. TRIM24-PAX6 interaction was examined through co-immunoprecipitation (Co-IP) and deubiquitination assays. Additional assays included colony formation, terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining, WB detection of phosphorylated histone H2AX (γ-H2AX) for DNA damage, epithelial-mesenchymal transition (EMT) marker analysis, sphere formation, and stemness marker assessments. In vivo drug resistance was tested using a mouse subcutaneous xenograft model. ART enhanced sunitinib sensitivity in resistant RCC cells, reducing colony formation, inducing apoptosis, elevating γ-H2AX, and upregulating TRIM24. ART enhances sunitinib sensitivity in RCC cells by upregulating TRIM24 expression, which facilitates the ubiquitination of PAX6. This process leads to the suppression of EMT and stem cell-like transitions in RCC cells.

Keywords: EMT; PAX6; TRIM24; artesunate; renal cancer.

PubMed Disclaimer

References

    1. Babaei, G., S. G. Aziz, and N. Z. Z. Jaghi. 2021. “EMT, Cancer Stem Cells and Autophagy; the Three Main Axes of Metastasis.” Biomedicine & Pharmacotherapy 133: 110909. https://doi.org/10.1016/j.biopha.2020.110909.
    1. Bai, M., C. He, S. Shi, et al. 2021. “Linc00963 Promote Cell Proliferation and Tumor Growth in Castration‐Resistant Prostate Cancer by Modulating miR‐655/TRIM24 Axis.” Frontiers in Oncology 11: 636965. https://doi.org/10.3389/fonc.2021.636965.
    1. Bai, Y., Y. You, D. Chen, et al. 2024. “Amiloride Reduces Fructosamine‐3‐Kinase Expression to Restore Sunitinib Sensitivity in Renal Cell Carcinoma.” iScience 27: 109997. https://doi.org/10.1016/j.isci.2024.109997.
    1. Cao, D., D. Chen, J. N. Xia, et al. 2022. “Artesunate Promoted Anti‐Tumor Immunity and Overcame EGFR‐TKI Resistance in Non‐Small‐Cell Lung Cancer by Enhancing Oncogenic TAZ Degradation.” Biomedicine & Pharmacotherapy 155: 113705. https://doi.org/10.1016/j.biopha.2022.113705.
    1. Chen, Y. W., L. Wang, J. Panian, et al. 2023. “Treatment Landscape of Renal Cell Carcinoma.” Current Treatment Options in Oncology 24: 1889–1916. https://doi.org/10.1007/s11864‐023‐01161‐5.

MeSH terms

LinkOut - more resources